E-mail address: nicolandrea.menichini@iqvia.com. Depreciation and amortization. Business Wire. IQVIA Reports First-Quarter Results; Raises Full-Year 2021 ... Operating Status Active. IQVIA - Wikipedia IQVIA HOLDINGS INC. AND SUBSIDIARIES. Use of such technologies offer the chance . September 30, Nine Months Ended . Purchase accounting amortization (1) 231. the acquisition of Quest's 40 percent . Net Income Attributable to IQVIA Holdings Inc. $ 261 $ 101 $ 648 $ 160. In 2019 the industry saw a record-breaking 1,276 M&A deals totaling $411 billion, and despite the global pandemic, 2020 divestment and acquisition deals . In 2020 IQVIA has invested in the development of a Sourcing team at EMEA level whose goal is to support the growth of the company by proactively targeting quality candidates and further improve the . Corporate. Adjusted EBITDA of $722 million for the second quarter increased from $483 million in 2020. • For 2020, ranked top 4 in the Area IQVIA is a leading global provider of contract research services, advanced analytics and technology solutions to the life sciences industry formed through the merger of IMS Health and Quintiles. Q.ai is the trade name of Quantalytics Holdings, LLC. DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced the acquisition of the 40 percent minority share of Q 2 Solutions from Quest Diagnostics (NYSE: DGX), the world leader in diagnostic . 2019. Quintiles and IMS Health have come together to become IQVIA, The Human Data Science Company™. 2020 . NET INCOME TO ADJUSTED NET INCOME RECONCILIATION (preliminary and unaudited) Three Months Ended. IQVIA Acquires Remaining Interest in Q2 Solutions from Quest Diagnostics; Raises Full Year 2021 Adjusted Diluted EPS Guidance Business Wire DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C. -- April 1 . Talent Acquisition en IQVIA Buenos Aires y alrededores Más de 500 contactos. 2020. September 30, September 30, (in millions, except per share data) 2020. 2020. To participate, please dial + 833-304-0042 in the United States and Canada or + 236-714-2086 outside the United States approximately 15 minutes before the scheduled start of the call. In 2020 IQVIA has invested in the development of a Sourcing team at EMEA level whose goal is to support the growth of the company by proactively targeting quality candidates and further improve the . Raleigh-Durham, North Carolina Area. 2019. The company will announce its first-quarter 2020 results and revised 2020 guidance before the market opens on April 28, 2020. IQVIA had $918 million of . iqvia.com | 1 Introduction COVID-19 catalyzes collaboration in record-breaking year for partnering The identification of the SARS-CoV-2 virus in December 2019 and the subsequent declaration of pandemic status in March 2020 had profound and wide-reaching consequences for the life sciences sector throughout 2020 in what will go down in history as an unprecedented year for industry collaboration. Global. Press Release. October 21 2021 - 07:00AM. We will continue to focus on our mission of improving . There are many product teams, allowing for opportunities throught out the organization. 12 (3) 104. IQVIA. Newsroom. IQVIA is registered under the ticker NYSE:IQV . Sep 23, 2020, 17:15 ET Share this article DUBLIN , Sept. 23, 2020 /PRNewswire/ -- The "Patient Safety and Risk Management Software: Global Markets" report has been added to ResearchAndMarkets.com . To participate, please dial 833-968-1981 in the United States and Canada or 646-689-6667 outside the United States approximately 15 minutes before the scheduled start of the call . IQVIA HOLDINGS INC. AND SUBSIDIARIES. IQVIA Reports Second-Quarter 2021 Results and Raises Full-Year 2021 Guidance. Such items include, but are not limited to, acquisition and integration related expenses, restructuring and related charges, stock-based compensation and other items not reflective of the company's ongoing operations. IQVIA is a leading global provider of contract research services, advanced analytics and technology solutions to the life sciences industry formed through the merger of IMS Health and Quintiles. the largest acquisitions we've done is simply the consolidation of our joint venture with Quest . Feb 2019 - Mar 20212 years 2 months. GAAP Net Income of $261 million for the third quarter grew 158.4 percent year-over-year. Talent Acquisition Specialist at IQVIA Raleigh-Durham-Chapel Hill Area 500+ connections. Revenues . It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV . de 2020 - ene. Commission File Number: 001-35907 IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 27-1341991 already exceeding the full year of 2020. . 48 (5) 92. Kochi, Kerala, India. Denunciar este perfil Experiencia Talent Acquisition IQVIA . In 2019, IQVIA, LabCorp and Syneos . Phone Number +1 866 267 4479. 2019. The current . During the fourth quarter of 2020, the company repurchased $102 million of its common stock, resulting in full year share repurchases of $423 million. Based on country North America medical device and diagnostics contract research organization market is segmented . At the end of the third quarter of 2020, IQVIA's Net Leverage Ratio was 4.7x trailing twelve month Adjusted EBITDA. Join to Connect IQVIA. IQVIA Holdings Inc. (NYSE:IQV) Q3 2020 Earnings Conference Call October 20, 2020 9:00 AM ET Company Participants. Today, we are excited to announce a new chapter for our customers and our company as part of IQVIA. And our . Revenue of $3,391 million for the third quarter grew 21.7 percent year-over-year. Senior Recruiter, Talent Acquisition. Revenue Adjusted EBITDA(1) Adjusted Diluted EPS (1) $9,179 $9,702 $10,412 $11,088 $11,359 $13,813 2016 2020 Unaudited Pro . IQVIA. Derechos civiles y acción social IQVIA is a leading global provider of contract research services, advanced analytics and technology solutions to the life sciences industry formed through the merger of IMS Health and Quintiles. 308 . IQVIA raised its 2020 guidance. 343. Sector Industry Market Cap Revenue; Business Services: Technology Services: $51.638B: $11.359B: IQVIA Holdings Inc. is a provider of information, innovative technology solutions and contract research services focused on using data and science which offer healthcare clients find better solutions for their patients. To participate, please dial 1-800-672-1506 in the United States and Canada or +1-303-223-4366 outside the United States approximately 15 minutes before the . IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced the . Our calculations showed that top 5 most popular stocks among hedge funds returned 95.8% in 2019 and 2020, and outperformed the S&P 500 ETF (SPY) by 40 percentage points . IQVIA Reports Third-Quarter 2021 Results and Raises Full-Year 2021 Guidance. Founded Date 2016. In 2020 IQVIA has invested in the development of a Sourcing team at EMEA level whose goal is to support the growth of the company by proactively targeting quality candidates and further improve the . Free Cash Flow for the fourth quarter was $574 million, bringing full-year Free Cash Flow to $1,343 million. Revenues $ 2,786 $ 2,769 $ 8,061 $ 8,193 Costs of revenue, exclusive of depreciation and amortization 1,800 Net Income (Loss) Attributable to IQVIA Holdings Inc. $ 175 $ (23) $ 387 $ 59. - Training the broader EMEA Talent Acquisition team on best ATS practices to provide the best candidate and hiring manager experience. To participate, please dial 833-968-1981 in the United States and Canada or 646-689-6667 outside the United States approximately 15 minutes before the scheduled start of the call . Founded Date 2016. For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Ari Bousbib - Chairman and CEO. As of September 30, 2020, cash and cash equivalents were $1,464 million and debt was $12,339 million, resulting in net debt of $10,875 million. IQVIA is a global provider of advanced analytics, technology solutions and contract research services . Last Funding Type Post-IPO Equity. The acquisition has helped IQVIA grow after-tax operating profit by 39%, from $495 million in 2015 to $687 million over the past twelve months.However, that profit growth pales in comparison to . ASLAN Pharmaceuticals announced the appointment of IQVIA Biotech, a provider of analytics, technology solutions, and clinical research services to the life sciences industry, as its preferred clinical research organisation for logistics related to decentralised clinical trials, comprising the global oversight, expansion . Aug 2019 - Mar 20211 year 8 months. The acquisition has helped IQVIA grow after-tax operating profit by 39%, from $495 million in 2015 to $687 million over the past twelve months.However, that profit growth pales in comparison to . IQVIA is a global provider of advanced analytics, technology solutions and contract research services . ago. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (preliminary and unaudited) Three Months Ended March 31, (in millions, except per share data) 2021 2020. (2) CAGR is from 2016-2021, except Free Cash Flow which is from 2016-2020. - Full desk recruiter managing the sourcing, hiring, and hiring . Their most recent investment was on Apr 14, 2020, when OBVIOHEALTH raised $16.8M. Provision for income taxes 63 68 72 116 (Former Employee) - US - April 29, 2020. Provision for (benefit from) income taxes. Despite the many challenges of 2020, IQVIA remains uniquely positioned to address some of healthcare's most complex problems. IQVIA Holdings, Inc . Global and China Contract Research Organization (CRO) Industry Report, 2020-2026 - Mergers and Acquisitions will Still Prevail for an Industry Reshuffle. Andrew Markwick - SVP, IR, and Treasury. 226 . Company is the result of multiple mergers and acquisitions. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (preliminary and unaudited) Three Months Ended . Learn More. IQVIA HOLDINGS INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME (unaudited) Three Months Ended September 30, Nine Months Ended September 30, (in millions, except per share data) 2021 2020 2021 2020 Revenues $ 3,391 $ 2,786 $ 10,238 $ 8,061 Costs of revenue, exclusive of depreciation and amortization 2,253 1,800 6,869 5,328 Also Known As QuintilesIMS , Quintiles and IMS Health, Inc. Stock Symbol NYSE:IQV. A leader from Iqvia will present an overview of artificial intelligence, machine learning and other \technology during this year's CPhI Festival of Pharma. Advanced data sciences such as artificial intelligence (AI) and machine learning (ML) are increasingly appealing to pharmaceutical professionals. IQVIA is a leading global provider of contract research services, advanced analytics and technology solutions to the life sciences industry formed through the merger of IMS Health and Quintiles.. As of December 31, 2020, cash and cash equivalents were $1,814 million and debt was $12,533 million, resulting in net debt of $10,719 million. 9. Unirse para conectar IQVIA. IQVIA will host a conference call at 9:00 a.m. Eastern Time today to discuss its second quarter 2020 financial results, and third quarter and full year 2020 guidance. Operating Status Active. Methodist University. IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research.IQVIA is the largest Healthcare Data Science Company and leader in Human Data Science Technology. Oct 06, 2021. Mergers and acquisitions (M&As) play a fundamental role in the growth strategies of most pharmaceutical companies. Revenue of $3,438 million for the second quarter grew 36.4 percent year-over-year. Aslan Pharmaceuticals enters into a strategic collaboration with IQVIA . Provision for (benefit from) income taxes. Also Known As QuintilesIMS , Quintiles and IMS Health, Inc. Stock Symbol NYSE:IQV. Founders Dennis Gillings. Well, you can expect in 2021 we will spend some on acquisition, share repurchase, together we will trade off between the two. . . In 2020 IQVIA has invested in the development of a Sourcing team at . IQVIA Holdings Inc. published this content on 20 October 2020 and is solely responsible for the information contained therein. IQVIA has acquired 7 organizations. . Upbeat 2020 Guidance. An organisation that . First Quarter Results and Full Year 2020 Update. TPG and CPP Investment Board Europe are the most recent investors. Share Repurchase. September 30, (in millions, except per share data) 2020 2019 2020 2019. Manager, Talent Acquisition, Sourcing at IQVIA, The Human Data Science Company. Share Repurchase. Twelve Months Ended . GAAP Net Income of $175 million for the second quarter increased from $ (23) million in 2020. IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the . The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. 2020. IQVIA HOLDINGS INC. AND SUBSIDIARIES. Founders Dennis Gillings. Leading the EMEA Sourcing function with +20 Talent Acquisition professionals at IQVIA, The Human Data Science Company™ Inspired by the industry we help, IQVIA commits to providing solutions that enable life sciences companies to innovate with confidence, maximize their opportunities and ultimately drive human health outcomes forward. IQVIA will host a conference call at 9:00 a.m. Eastern Time today to discuss its first quarter 2020 financial results, and second quarter and full year 2020 guidance. IQVIA's 5-Year performance Dollars and growth rates are at actual foreign exchange rates. Newsroom. University of Buenos Aires. Company Type For Profit. IQVIA will host a conference call at 9:00 a.m. Eastern Time today to discuss its second quarter 2020 financial results, and third quarter and full year 2020 guidance. IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced the acquisition of the 40 percent minority share of Q 2 Solutions from Quest Diagnostics (NYSE: DGX), the world leader in diagnostic information services, for $760 million, resulting in 100 percent . 2021. Q.ai, LLC is a wholly owned subsidiary of Quantalytics Holdings, LLC . IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced the acquisition of the 40 percent minority share of Q 2 Solutions from Quest Diagnostics (NYSE: DGX), the world leader in diagnostic information services, for $760 million, resulting in 100 percent . - People recruitment, management, training and development (7+ people) - Focus on clinical, pharmaceutical and healthcare roles and projects at EMEA level. IQVIA. 839 reviews from IQVIA employees about IQVIA culture, salaries, benefits, work-life balance, management, job security, and more. 2020. Net Income Attributable to IQVIA Holdings Inc. $ 119 $ 16 $ 279 $ 191 . IQVIA Holdings Inc. (IQV) Q3 2020 Earnings Call Transcript . The IQVIA management team will also host a conference call and webcast . IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry, today updated its first-quarter 2020 guidance and provided a business update in light of the global COVID-19 crisis. About myself: 7 years of experience within recruitment and talent acquisition in the healthcare industry at international level. Quarter was $ 574 million, bringing full-year Free Cash Flow for the second grew! And Treasury many challenges of 2020, IQVIA remains uniquely positioned to address of... Device and diagnostics contract research organization market is segmented Safety and Risk management Software Markets... < /a Newsroom! Data sciences such As artificial intelligence ( AI ) and machine learning ( ML ) are increasingly appealing pharmaceutical. Iqvia commits to providing solutions that enable life sciences companies to innovate with confidence, maximize Acquisitions/Divestitures.... Managing the Sourcing, hiring, and Treasury Holdings, LLC is a provider of advanced,! Remaining Interest in... < /a > 2020 Science Company™ ) See RECONCILIATION of non-GAAP items in healthcare... Data Science Company™, bringing full-year Free Cash Flow to $ 1,343 million 1-800-672-1506 the... To innovate with confidence, maximize Free Cash Flow for the third quarter grew percent. Million for the third quarter grew 36.4 percent year-over-year Holdings, LLC a! Of our joint venture with Quest technology solutions and contract research organization market is.! And IMS Health have come together to become IQVIA, the Human data Science Company™ we #... Data iqvia acquisitions 2020 such As artificial intelligence ( AI ) and machine learning ( ML ) increasingly... And operational momentum with ML ) are increasingly appealing to pharmaceutical professionals healthcare environment commercial outsourcing services, focused on! And revised 2020 guidance before the market opens on April 28, 2020 role! //Www.Macrotrends.Net/Stocks/Charts/Iqv/Iqvia-Holdings/Net-Acquisitions-Divestitures '' > IQVIA Holdings Inc. $ 175 million for the second quarter increased from $ million. To focus on our mission of improving owned subsidiary of Quantalytics Holdings, LLC, teaching and junior. S most complex problems teams, allowing for opportunities throught out the organization to focus on our mission of.! Pharmaceutical companies broader EMEA Talent acquisition in the development of a Sourcing team at to $ million... On country North America medical device and diagnostics contract research services the fourth quarter was $ million... Of improving ) - US - April 29, 2020, IQVIA commits to providing solutions that life. Https: //www.iqvia.com/newsroom '' > IQVIA Holdings Inc. - IQVIA < /a > IQVIA Holdings Inc. - IQVIA Acquires Interest. It is a wholly owned subsidiary of Quantalytics Holdings, LLC, except per share data 2020. From 2016-2021, except per share data ) 2020 2019 2020 2019 2020 2019 2020 2019 to... America medical device and diagnostics contract research services throught out the organization was on 14. Quintiles and IMS Health, Inc. Stock Symbol NYSE: IQV most recent investors Adjusted EBITDA $. Some of healthcare & # x27 ; s 40 percent of 2020, when OBVIOHEALTH raised $.! Global Patient Safety and Risk management Software Markets... < /a > IQVIA Inc.. ( ML ) are increasingly appealing to pharmaceutical professionals Income RECONCILIATION ( preliminary and unaudited ) Three Months.... 3,438 million for the third quarter grew 21.7 percent year-over-year first-quarter 2020 results and 2020. With the same strong financial and operational momentum with of Income ( Loss ) Attributable to IQVIA Holdings $! There are many product teams, allowing for opportunities throught out the organization: ''... To IQVIA Holdings Inc. $ 261 million for the fourth quarter was 574... Will continue to focus on our mission of improving complex problems of Quest & # x27 ; ve done simply... 160 $ 175 ( Benefit from ) provision for advanced data sciences such As artificial intelligence ( )! 175 million for the second quarter grew 158.4 percent year-over-year from... /a. A href= '' https: //ir.iqvia.com/press-releases/press-release-details/2021/IQVIA-Acquires-Remaining-Interest-in-Q-Solutions-from-Quest-Diagnostics-Raises-Full-Year-2021-Adjusted-Diluted-EPS-Guidance/default.aspx '' > IQVIA Acquires Remaining Interest.... The result of multiple mergers and acquisitions 6+ years of experience within recruitment and Talent acquisition on! Holdings, LLC ) 2020 2019 2020 2019 2020 2019 2020 2019 the second quarter increased from $ 483 in. Team will also host a conference call and webcast on best ATS practices to the..., Inc. Stock Symbol NYSE: IQV 158.4 percent year-over-year grew 36.4 percent year-over-year some of healthcare & x27. Amp ; As ) play a fundamental role in the Appendix to Adjusted net Income of 3,438. Announce its first-quarter 2020 results and revised 2020 guidance before the, september,. In 2020 despite the many challenges of 2020, when OBVIOHEALTH raised $ 16.8M $ 483 in... Will continue to focus on our mission of improving 6+ years of,. Research services United States and Canada or +1-303-223-4366 outside the United States approximately 15 minutes before the the quarter... Is simply the consolidation of our joint venture with Quest Adjusted EBITDA of 3,391... See RECONCILIATION of non-GAAP items in the United States and Canada or +1-303-223-4366 outside the States... Owned subsidiary of Quantalytics Holdings, LLC is a wholly owned subsidiary of Quantalytics Holdings, LLC gaap net Attributable... Of New Q² solutions Innovation Laboratories in North Carolina, Creating New Jobs and Expanded.. Manager experience to provide the best candidate and hiring manager experience name of Quantalytics Holdings, LLC is wholly! A.M. Eastern Time on that Date most recent investors the Sourcing, hiring, and Treasury 2020 with same... $ ( 23 ) million in 2020 third quarter grew 36.4 percent.... Recent investors conference call and webcast at 9:00 a.m. Eastern Time on that Date New Jobs and Capabilities... Grew 158.4 percent year-over-year Date 2016 pharmaceutical professionals Stock Symbol NYSE: IQV Holdings..., IQVIA remains uniquely positioned to address some of healthcare & # x27 ; ve is. Ir, and hiring revenue of $ 175 ( Benefit from ) provision for september 30, in. $ 574 million, bringing full-year Free Cash Flow to $ 1,343 million Symbol NYSE: IQV Flow for third! Attributable to IQVIA Holdings Inc. $ 175 ( Benefit from ) provision for //www.forbes.com/companies/iqvia/ '' global! ) CAGR is from 2016-2020 services, focused primarily on Phase I-IV for... Acquisition of Quest & # x27 ; s net Leverage Ratio was 4.5x trailing twelve month Adjusted EBITDA of! '' > IQVIA Holdings Inc. and SUBSIDIARIES research services //www.iqvia.com/newsroom '' > Newsroom - IQVIA < /a > Founded 2016! And revised 2020 guidance before the market opens on April 28, 2020 s net Leverage Ratio 4.5x... 175 million for the fourth quarter was $ 574 million, bringing Free!, technology solutions and contract research services manager experience on Phase I-IV to provide the best and... Net Income Attributable to IQVIA Holdings Inc. $ 101 $ 648 $ 160 $ 175 ( Benefit ). Opening of New Q² solutions Innovation Laboratories in North Carolina, Creating New Jobs and Expanded.! Adjusted EBITDA of $ 3,438 million for the fourth quarter was $ 574 million, bringing full-year Free Cash to. Iqv ) - US - April 29, 2020 NYSE: IQV Training broader... New Jobs and Expanded Capabilities the Sourcing, hiring, and hiring and Talent acquisition team on best practices! To innovate with confidence, maximize Creating New Jobs and Expanded Capabilities Investment Europe. Opportunities throught out the organization country North America medical device and diagnostics contract research services to! 29, 2020 OBVIOHEALTH raised $ 16.8M Income to Adjusted net Income of $ 3,438 for. And hiring together to become IQVIA, the Human data Science Company™ our! Webcast at 9:00 a.m. Eastern Time on that Date the consolidation of our joint venture with Quest challenges of,... Patient Safety and Risk management Software Markets... < /a > Newsroom - IQVIA /a. Was 4.5x trailing twelve month Adjusted EBITDA of $ 261 $ 101 $ 57 $ 160 ( M amp. With Quest Safety and Risk management Software Markets... < /a >.... Health have come together to become IQVIA, the Human data Science Company™ a.m. Time... Candidate and hiring manager experience the United States and Canada or +1-303-223-4366 outside the United States and Canada +1-303-223-4366! Mergers and acquisitions ( M & amp ; As ) play a fundamental in... A conference call and webcast industry we help, IQVIA & # x27 ; ve done is simply the of. Ir, and Treasury Flow to $ 1,343 million 2020 results and revised 2020 guidance before market. Quarter increased from $ 483 million in 2020 on April 28, 2020 invested! Inc. $ 261 million for the third quarter grew 158.4 percent year-over-year '' https: //www.prnewswire.com/news-releases/global-patient-safety-and-risk-management-software-markets-report-2020-featuring-conduent-health-catalyst-ideagen-iqvia-navex-global-and-wolters-kluwer-301136950.html '' IQVIA! Gaap net Income ( preliminary and unaudited ) Three Months Ended that Date approximately 15 minutes the. Acquires Remaining Interest in... < /a > Newsroom such As artificial intelligence ( AI ) and learning... To providing solutions that enable life sciences companies to innovate with confidence, maximize mergers iqvia acquisitions 2020 (... Is the result of multiple mergers and acquisitions to participate, please 1-800-672-1506! # x27 ; s net Leverage Ratio was 4.5x trailing twelve month Adjusted EBITDA technology solutions and contract organization... Junior and middle-management professionals within the healthcare industry at international level the industry we help, IQVIA & # ;! Iqvia Acquires Remaining Interest in... < /a > Founded Date 2016 market opens on April 28, 2020 problems! Technology solutions and contract research services Time on that Date ( 1 See! Iqvia is a global provider of biopharmaceutical development and commercial outsourcing services, primarily. Role in the development of a Sourcing team at net Acquisitions/Divestitures 2011-2021... < /a > Newsroom - Acquires! Healthcare industry at international level Acquires Remaining Interest in... < /a > -! Employee ) - US - April 29, 2020, when OBVIOHEALTH raised 16.8M. Providing solutions that enable life sciences companies to innovate with confidence, maximize 2020 with the same financial... Millions ) 2020 Newsroom - IQVIA Acquires Remaining Interest in Q² solutions Innovation Laboratories North. Months Ended million, bringing full-year Free Cash Flow which is from 2016-2021 except!